Four Stocks To Watch: Twenty-First Century Fox Inc (FOXA), QUALCOMM Inc. (QCOM), DryShips Inc. (DRYS), Ariad Pharmaceuticals Inc. (ARIA)

Neha Gupta - October 4, 2014

Boston, MA 10/04/2014 (wallstreetpr) – Leonardo DiCaprio, who is currently acting in Twenty-First Century Fox Inc (NASDAQ:FOXA)‘s most awaited movie ‘ The Revenant,’ has decided to take a break from acting career for some time. He was slated to work in Walter Isaacson’s biography of Steve Jobs. It is currently learnt that DiCaprio has said no to ‘Steve Jobs’ movie, which is to be made by Sony Corp. Steve Jobs project has brought some of the best talent from industry under one roof. The project consists of top names like Danny Boyle and Aaron Sorkin. Shares of Twenty-First Century Fox Inc (NASDAQ:FOXA) inched up by 1.98% to close at $34.07.

QUALCOMM, Inc. (NASDAQ:QCOM) finds a big opportunity in auto sector. Kanwalinder Singh, Senior Vice President of QCOM stated that “What goes into a car is actually more than high-end smartphone silicon content,” which means that an auto would require more chips compared to what a smartphone needs. Shares of QUALCOMM, Inc. (NASDAQ:QCOM) were up by 1.64% to close at $74.86.

DryShips Inc. (NASDAQ:DRYS) announced the public offering of its Senior Secured Notes which are due in 2017. As per the information, DRYS wants to use the net proceedings of this offering for repaying the outstanding principal amount of 5% Convertible Senior Notes, which are due on December 1, 2014. The total outstanding amount is $700 million. DRYS have decided to secure these shares by first priority liens on a few shares of Ocean Rig UDW Inc.’s common stock. Ocean Rig UDW Inc. is a wholly owned subsidiary of DRYS. As per the reports, these notes will be offered in minimum denominations of $1,000 and multiple of $1,000 thereafter. It has decided to offer sole book-running manager’s post to Sterne, Agee & Leach Inc. At the same time Cowen and Company, LLC and DNB Markets have been appointed as co-managers for this offering.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) after spiking by 12.86% on Thursday saw some profit taking in Friday’s trading session. Shares of the company fell by 1.71% to close at $5.75. A look at daily chart suggests that there has been quite a bit of price volume action happening in the scrip since last four days. Though volume of 19.91 million in Thursday’s trading session was majorly attributed to the news of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s AP26113 getting breakthrough status from FDA for the treatment of Cancer. Shares of the company are currently trading above its 20-Day EMA of $5.72 and below its 50-Day EMA of $5.86 with RSI of 49.83. In the near term the stock has support at $5.65 and $5.40 while resistance at $5.90 and $6.20.

Neha Gupta

Swati has worked in diverse capacities from financial research to currency trading in a span of 3 years.

Leave a Reply

Your email address will not be published. Required fields are marked *